Is Ajooni Biotech Ltd (AJOONI) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Ajooni Biotech Ltd is a below average quality company .

Is Ajooni Biotech Ltd (AJOONI) undervalued or overvalued?

The key valuation ratios of Ajooni Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Ajooni Biotech Ltd (AJOONI) share price return in the past 10 years?

Data is not available for this company

Is Ajooni Biotech Ltd (AJOONI) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Ajooni Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Ajooni Biotech Ltd (AJOONI)?

Company share prices are keep on changing according to the market conditions. The current trading price of Ajooni Biotech Ltd (AJOONI) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Ajooni Biotech?

The latest standalone P/E ratio of Ajooni Biotech as of 01-Jan-1970 is 14.92.

What is the P/B ratio of Ajooni Biotech Ltd (AJOONI)?

The latest standalone P/B ratio of Ajooni Biotech Ltd (AJOONI) as of 01-Jan-1970 is 0.81.

What is the 52-week high and low of Ajooni Biotech Ltd (AJOONI)?

The 52-week high of Ajooni Biotech Ltd (AJOONI) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Ajooni Biotech Ltd (AJOONI) Share Analysis – Brand Strength, Quality & Valuation Zone & DeciZen Rating

Name: Ajooni Biotech Ltd (AJOONI)
Brand: Ajooni Biotech

Ajooni Biotech Ltd (AJOONI) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹73 Cr.

P/E Ratio

14.92

Price to Book (P/B)

0.81

Price to Sales (P/S)

0.48

EV/EBITDA

9.56

Return on Capital Employed (ROCE)

6.94%

Current Price

₹0

Return on Equity (ROE)

5.18%

Return on Assets (ROA)

4.75%

Operating Profit Margin

3.2%

Net Profit Margin

2.94%

Gross Profit Margin

4.7%

Book Value per Share

₹5.3

Sales Growth (YoY)

43.17%

Sales Growth (3 Years)

15.71%

Operating Profit Growth (1 Year)

65.47%

Operating Profit Growth (3 Years)

7.99%

Net Profit Growth (1 Year)

56.02%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

47.59%

Dividend Yield

0.00%

Promoter Holding

26.89%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Ajooni Biotech Ltd?

Ajooni Biotech Ltd revenue growth is 43.2% for FY-2025 , which is above its 5 year CAGR of 23.4% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Ajooni Biotech Ltd?

Promoters hold 26.89% of the Ajooni Biotech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Ajooni Biotech Ltd vs industry peers?

Ajooni Biotech Ltd revenue CAGR is 23.43% , compared to the industry median CAGR of 6.14% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Ajooni Biotech Ltd belong to?

Ajooni Biotech Ltd belongs to the FMCG sector, operating specifically within the Animal Feed segment.

Q.1 Stock return of Ajooni Biotech Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -33.3% based on the current price.

DeciZen - make an informed investing decision on Ajooni Biotech

Based on:

Data

M-Cap below 100cr DeciZen not available

Ajooni Biotech stock performance

Key Ratios

Is Ajooni Biotech Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	18.6%	36.2%	10%	3.8%	4.4%	5.1%	9.1%	6%	7.8%	6.9%	-
Value Creation Index ⓘ	0.3	1.6	-0.3	-0.7	-0.7	-0.6	-0.4	-0.6	-0.5	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	13.2	28.5	42.4	39.7	40	51	74	74.5	80.1	115	151
Sales YoY Gr.	-	115.7%	48.5%	-6.3%	0.8%	27.5%	45.1%	0.6%	7.5%	43.2%	-
Adj EPS ⓘ	0.3	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.3
YoY Gr.	-	100%	-77.8%	-41.7%	0%	0%	200%	-38.1%	7.7%	7.1%	-
BVPS (₹) ⓘ	1.5	1.9	3.2	3.4	3.3	3.1	3.3	4.8	4.9	5.1	5.3
Adj Net Profit ⓘ	0.1	0.3	0.4	0.2	0.3	0.4	1.1	1.1	1.2	2.6	5
Cash Flow from Ops. ⓘ	-0.6	0	0	-4.9	-4.4	1.2	3.7	-5.6	22.9	-17.7	-
Debt/CF from Ops. ⓘ	-1.3	0	0	-1	-1.2	5.9	1.5	-0.9	0.1	-0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	27.1%	23.4%	15.7%	43.2%
Adj EPS ⓘ	-6.3%	16.5%	-10.6%	7.1%
BVPSⓘ	15%	8.8%	15.9%	4.5%
Share Price	-	-33.4%	-4.3%	-29.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	20.4	36.6	6.3	1.9	2.3	2.4	6.6	3.9	2.9	3.9	5.4
Op. Profit Mgn % ⓘ	1.7	2.3	2.2	1.8	3.1	3.2	4	3.7	2.8	3.2	4.2
Net Profit Mgn % ⓘ	0.7	1	0.9	0.6	0.8	0.7	1.4	1.5	1.5	2.2	3.2
Debt to Equity ⓘ	1.5	0.6	0.5	0.4	0.3	0.4	0.3	0.1	0.1	0	0.1
Working Cap Days ⓘ	46	51	53	85	135	138	106	171	185	169	181
Cash Conv. Cycle ⓘ	12	2	17	58	103	98	64	73	100	101	165

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.3	-
TTM Sales (₹ Cr.)	151	-
BVPS (₹) ⓘ	5.3	-
Reserves (₹ Cr.) ⓘ	57	-
P/BV ⓘ	0.81	-
PE ⓘ	14.92	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	73.2
Equity (₹ Cr.)	34.5
Face Value (₹)	2
Industry PE ⓘ	25.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Ajooni Biotech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	13.23	28.53	42.37	39.72	40.03	51.04	74.04	74.49	80.11	114.69
Operating Expenses ⓘ +	13	27.87	41.44	39.01	38.82	49.39	71.10	71.72	77.88	111
Manufacturing Costs	0.34	0	0.91	0.78	0.86	1.42	1.66	1.37	1.43	1.64
Material Costs	10.99	24.36	37.69	36.47	34.91	43.01	64.01	65.74	70.35	97.03
Employee Cost	0.43	0.59	0.88	0.72	1.12	1.15	1.48	1.76	1.80	2.76
Other Costs ⓘ	1.24	2.91	1.96	1.04	1.93	3.81	3.95	2.85	4.30	9.58
Operating Profit ⓘ	0.23	0.67	0.93	0.71	1.21	1.65	2.93	2.77	2.23	3.69
Operating Profit Margin (%)	1.7%	2.3%	2.2%	1.8%	3.0%	3.2%	4.0%	3.7%	2.8%	3.2%
Other Income ⓘ +	0	0.05	0.22	0.34	0.09	0.02	0.04	0.29	2.19	2.07
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.02	0.14	0.35	0.13	0.33	0.58	0.54	0.48	0.56	0.33
Depreciation ⓘ	0.07	0.19	0.31	0.44	0.49	0.58	0.97	1	0.87	1.09
Profit Before Tax ⓘ	0.14	0.39	0.49	0.47	0.48	0.50	1.46	1.58	3	4.33
Tax ⓘ	0.04	0.11	0.10	0.06	0.13	0.13	0.41	0.45	0.83	0.96
Profit After Tax	0.10	0.28	0.39	0.41	0.35	0.37	1.05	1.12	2.16	3.37
PAT Margin (%)	0.7%	1.0%	0.9%	1.0%	0.9%	0.7%	1.4%	1.5%	2.7%	2.9%
Adjusted EPS (₹)	0.3	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0.52	0.97	10.94	12.16	15.89	15.65	16.38	41.67	42.71	88.08
Share Capital ⓘ	0.24	0.33	5.86	6.16	8.41	10.01	10.01	17.52	17.52	34.45
Reserves ⓘ	0.29	0.64	5.09	6.01	7.49	5.65	6.38	24.15	25.19	53.63
Debt +	0.78	0.62	4.51	4.77	5.03	5.86	4.40	4.62	1.68	1.94
Long Term Debt	0.25	0.62	0.27	4.16	1.33	1.90	2.58	1.75	1.68	1.94
Short Term Debt	0.54	0	4.23	0.61	3.69	3.96	1.82	2.87	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.81	5.25	0.93	1.16	1.93	5.40	6.80	10.11	1.58	3.50
Others Liabilities ⓘ	0.31	6.01	2.89	0.06	0.09	0.97	1.26	2.06	1.23	1.16
Total Liabilities ⓘ	2.42	12.85	19.27	18.16	22.94	27.88	28.84	58.46	47.21	94.67
Fixed Assets
Net Fixed Assets ⓘ +	0.30	1.14	1.04	1.02	2.07	3.60	6.21	6.29	10.32	10.93
Gross Block	0.30	1.43	1.65	1.93	3.33	5.29	8.87	9.96	14.87	16.58
Accumulated Depreciation	0	0.30	0.61	0.91	1.26	1.70	2.67	3.68	4.55	5.64
CWIP ⓘ	0	0	0	0	0	1.57	0	0.26	0.92	0.29
Investments ⓘ	0	5.71	6.02	3.76	3.08	1.15	0.70	3.74	2.14	3.49
Inventories	0.41	4.22	2	5.07	3.29	5.38	5.88	6.99	15.37	23.99
Trade Receivables	1.21	1.30	2.86	4.83	12.64	13.71	13.84	20.55	12.96	16.22
Cash Equivalents	0.07	0.10	5.30	0.73	0.12	0.24	0.06	0.31	0.43	6.83
Others Assets ⓘ	0.42	0.38	2.06	2.74	1.74	2.24	2.15	20.32	5.07	32.92
Total Assets ⓘ	2.42	12.85	19.27	18.16	22.94	27.88	28.84	58.46	47.21	94.67

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0.62	-4.92	-4.38	1.16	3.68	-5.58	22.91	-17.74
PBT ⓘ	0.14	0.47	0.48	0.50	1.46	1.58	3	4.33
Adjustment ⓘ	0.09	0.28	0.64	1.02	1.66	1.38	0.93	0.54
Changes in Working Capital ⓘ	-0.82	-5.55	-5.5	-0.36	0.72	-8.09	19.53	-21.73
Tax Paid ⓘ	-0.03	-0.12	-0	-0.01	-0.16	-0.45	-0.54	-0.88
Cash Flow From Investing Activity ⓘ +	-0.17	1.42	0.47	-3.41	-1.90	-15.82	7.64	-17.13
Capex	-0.17	1.97	0.40	-3.53	-2.02	-1.36	-5.57	-1.08
Net Investments	0	-0.56	0	0.12	0.13	-13.17	12.70	-16.95
Others ⓘ	0	0	0.07	0	0	-1.30	0.50	0.89
Cash Flow From Financing Activity ⓘ +	0.73	-1.06	3.30	2.37	-1.97	21.66	-3.57	24.83
Net Proceeds from Shares ⓘ	0	0.81	3.38	1.20	0	22.31	0	25.39
Net Proceeds from Borrowing ⓘ	0.25	1.97	-2.83	0.57	0.68	-0.83	-0.06	0.26
Interest Paid ⓘ	-0.02	-0.11	-0.33	-0.58	-0.54	-0.48	-0.56	-0.33
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	0.50	-3.73	3.08	1.19	-2.11	0.66	-2.94	-0.49
Net Cash Flow ⓘ	-0.06	-4.57	-0.61	0.12	-0.19	0.25	26.98	-10.04

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	20.38	36.98	6.8	3.72	2.54	2.4	6.58	3.87	5.12	5.18
ROCE (%)	18.62	36.19	10.03	3.84	4.35	5.07	9.09	5.99	7.75	6.94
Asset Turnover Ratio	6.56	3.74	2.64	2.12	1.95	2.01	2.61	1.71	1.52	1.62
PAT to CFO Conversion(x)	-6.2	0	0	-12	-12.51	3.14	3.5	-4.98	10.61	-5.26
Working Capital Days
Receivable Days	28	16	18	35	80	94	68	84	76	46
Inventory Days	11	30	27	32	38	31	28	32	51	63
Payable Days	31	45	30	10	16	31	35	47	30	10

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ajooni Biotech Ltd FAQs

The current trading price of Ajooni Biotech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Ajooni Biotech stood at ₹73.20 Cr

The latest P/E ratio of Ajooni Biotech as of 31-Dec-1969 is 14.92.

The latest P/B ratio of Ajooni Biotech as of 31-Dec-1969 is 0.81.

The 52-week high of Ajooni Biotech is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ajooni Biotech is ₹151 ( Cr.) .

About Ajooni Biotech Ltd

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ajooni Biotech Ltd (AJOONI) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating